Navi, India

Subhadra Devi Kashyap


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Subhadra Devi Kashyap: Innovator in Stem Cell Research

Introduction

Subhadra Devi Kashyap is a prominent inventor based in Navi, India. She has made significant contributions to the field of stem cell research, particularly in the development of pluripotent embryonic-like stem cells. Her work has the potential to revolutionize therapeutic approaches for various diseases and conditions.

Latest Patents

Kashyap holds a patent for "Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof." This patent describes mammalian pluripotent embryonic-like stem cells (ELSCs) isolated from corneal limbal tissue, which is a non-embryonic tissue. The ELSCs are capable of proliferating in vitro and maintain the potential to differentiate into cells of endoderm, mesoderm, and ectoderm lineage. They can also form embryoid-like bodies when placed in suspension culture. This multi-lineage differentiation potential and self-renewing capability make ELSCs a promising therapeutic tool for various diseases, conditions, and injuries. Kashyap has 1 patent to her name.

Career Highlights

Subhadra Devi Kashyap is currently associated with Reliance Life Science Pvt. Ltd., where she continues her research and development in the field of stem cells. Her innovative work has garnered attention and respect within the scientific community.

Collaborations

Kashyap has collaborated with notable colleagues such as Satish Mahadeorao Totey and Khan Firdos Alam. These collaborations have further enhanced her research capabilities and contributions to the field.

Conclusion

Subhadra Devi Kashyap is a trailblazer in stem cell research, with her innovative work paving the way for new therapeutic alternatives. Her contributions are vital in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…